Tag Archives: Type

FDA Approves Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) for Type 2 Diabetes

FDA Approves Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) for Type 2 Diabetes Print this page  3 May 2019 — The US Food and Drug Administration (FDA) has approved Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) extended release tablets as an oral adjunct treatment to diet and exercise to improve glycaemic control in adults with… Read More »

FDA stiff-arms Sanofi and Lexicon's Type 1 diabetes hopeful Zynquista

The FDA stiff-armed Sanofi and Lexicon’s diabetes drug Zynquista on Friday, darkening the companies’ hopes of launching the drug for Type 1 diabetes this year. It’s not a complete surprise, because an FDA advisory panel was split right down the middle on whether to approve the SGLT1/2 drug. But the FDA could have chosen the positive side… Read More »